Bendopnea and Its Clinical Importance in Outpatient Patients with Pulmonary Arterial Hypertension

about

Bendopnea and Its Clinical Importance in Outpatient Patients with Pulmonary Arterial Hypertension

Item

http://www.wikidata.org/entity/Q59131733

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Bendopnea and Its Clinical Imp ...... ulmonary Arterial Hypertension

@en

Bendopnea and Its Clinical Imp ...... ulmonary Arterial Hypertension

@nl

type

Item

label

Bendopnea and Its Clinical Imp ...... ulmonary Arterial Hypertension

@en

Bendopnea and Its Clinical Imp ...... ulmonary Arterial Hypertension

@nl

prefLabel

Bendopnea and Its Clinical Imp ...... ulmonary Arterial Hypertension

@en

Bendopnea and Its Clinical Imp ...... ulmonary Arterial Hypertension

@nl

P1476

Bendopnea and Its Clinical Imp ...... ulmonary Arterial Hypertension

@en

P2093

Aysen Agir

http://www.w3.org/2001/XMLSchema#string

Canan Baydemir

http://www.w3.org/2001/XMLSchema#string

Irem Karauzum

http://www.w3.org/2001/XMLSchema#string

Kurtulus Karauzum

http://www.w3.org/2001/XMLSchema#string

Serap Baris Argun

http://www.w3.org/2001/XMLSchema#string

Tayfun Sahin

http://www.w3.org/2001/XMLSchema#string

Teoman Kilic

http://www.w3.org/2001/XMLSchema#string

Ulas Bildirici

http://www.w3.org/2001/XMLSchema#string

Umut Celikyurt

http://www.w3.org/2001/XMLSchema#string

P2860

World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.

Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow?

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency.

Pulmonary arterial hypertension: advances in pathophysiology and management.

Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial.

Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

Five-Year outcomes of patients enrolled in the REVEAL Registry.

Exertional Dyspnoea in Chronic Respiratory Diseases: From Physiology to Clinical Application.

P304

518-525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6515/ACS.201811_34(6).20180528A

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30449993

http://www.w3.org/2001/XMLSchema#string

P932

6236562

http://www.w3.org/2001/XMLSchema#string